Metastatic Gastric Carcinoma

15 clinical trials · Condition

Record	Firm	Date
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines (NCT04535401)	National Cancer Institute (NCI)	2021-08-13
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)	National Cancer Institute (NCI)	2021-08-09
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)	M.D. Anderson Cancer Center	2021-05-12
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations (NCT04550494)	National Cancer Institute (NCI)	2021-04-26
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers (NCT04221893)	University of California, San Francisco	2020-08-07
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors (NCT02757391)	M.D. Anderson Cancer Center	2019-08-09
Intravital Microscopy in Human Solid Tumors (NCT03823144)	Mayo Clinic	2019-02-28
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery (NCT03008278)	National Cancer Institute (NCI)	2018-02-06

Every clearance here is in the API, with alerts when new ones post.